Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005214 |
---|---|
Receipt number | R000006105 |
Scientific Title | A randomized phase II study of a combination of docetaxel and bevacizumab versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with bevacizumab and platinum-based chemotherapy. |
Date of disclosure of the study information | 2011/03/08 |
Last modified on | 2012/09/10 17:37:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/08 10:44:40 | ||
2 | Update | 2011/03/09 09:05:06 | Narrative objectives1 |
|
3 | Update | 2011/10/11 09:17:37 | Recruitment status |
|
4 | Update | 2012/01/04 18:50:19 | Organization Organization Organization Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Email1 |
|
5 | Update | 2012/09/10 17:37:05 | Recruitment status |